Bone Marrow Transplant (BMT) Program
A Bone Marrow Transplant or BMT is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stemcells.
BMT is used most often to treat:
- acute leukemia (AML or ALLI)
- bone and soft-tissue sarcomas
- brain tumors, as well as other conditions
There are several types of BMT. The type of transplant depends on who donates the bone marrow or blood stem cells
The most common types are:
- Autologous Transplant
- Allogeneic Transplant
- Genetic matching or HLA matching
- Matched Unrelated Transplant
Learn more about this on the BMT - Treatment Information webpage.
The University of Michigan Blood and Marrow Transplantation Program offers compassionate care, multidisciplinary collaboration, and the late research innovations come together to help severely ill patients whose conditions require that they undergo this highly specialized treatment.
More than 200 adult BMT procedures are performed at U-M each year - making this one of the largest programs in the state. That level of experience means U-M transplant specialists know what to recommend for each transplant candidate, what to expect from each procedure, and how to respond to every challenge that may arise on the transplant journey.
Pediatric patients are cared for in our Blood & Marrow Transplant (Pediatric) Program.
The program's dedicated team of doctors, nurses, physician assistants and transplant coordinators are specially trained in and solely devoted to stem cell transplantation. Their focus is on performing the procedure safely and effectively; carefully monitoring and caring for patients before, during and after; and communicating with patients' referring physicians throughout the process. The multidisciplinary approach to care means that patients benefit from not just one expert opinion, but many. Care plans are personalized to meet the specific needs of each individual patient, and the entire care team meets several times each week to discuss each patient's progress.
The program is accredited by the Foundation for the Accreditation of Hematopoietic Cell Therapy and is also approved by the National Marrow Donor Program and the Southwest Oncology Group.
Behind the growth and success of the BMT Program at Michigan is its commitment to research. Through groundbreaking basic, translational and clinical research efforts, the University of Michigan has become an international leader in understanding and responding to the particular risks and consequences associated with BMT. In particular, Rogel Cancer Center researchers are at the forefront of the study and treatment of graft-vs.-host disease (GVHD), one of the most common and dangerous consequences of allogeneic transplantation. Because of this commitment to research, every patient can benefit from the very latest innovations to make transplantation safer and more effective.
Learn more on the Blood and Marrow Transplantation Research page.
In addition to medical treatment, tthe care team includes not only doctors and nurses specializing in BMT, but social workers, psychologists, nutritionists and patient educators trained to address the special needs of patients and their families. BMT patients and their families also have access to the Rogel Cancer Center's Patient Support Services Program, in addition to patient and guest services offered by Michigan Medicine. Please take time to visit the support services area of this website, which outlines the services available.
To make an appointment, please call 734-232-8838 (Monday-Friday, 8am-5pm EST). If you would like to refer a patient, please contact our M-Line service: 800-962-3555. For more information, visit our Referrals and Appointments web page.
Still have questions?
The nurses at Cancer AnswerLine have answers. Call 1-800-865-1125 and you'll get a personal response from one of our registered nurses, who have years of experience in caring for people with cancer.